These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29611351)

  • 1. Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteers.
    Bech AP; Wetzels JFM; Nijenhuis T
    Physiol Rep; 2018 Apr; 6(7):e13665. PubMed ID: 29611351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological insights into novel therapies for nephrogenic diabetes insipidus.
    Sands JM; Klein JD
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1149-F1152. PubMed ID: 27534996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil for the Treatment of Congenital Nephrogenic Diabetes Insipidus.
    Assadi F; Sharbaf FG
    Am J Nephrol; 2015; 42(1):65-9. PubMed ID: 26337818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in daily urine solute output in patients with NDI, CDI, SIADH, and NSIAD: Clinical implications.
    Decaux G
    Clin Nephrol; 2021 Oct; 96(4):233-238. PubMed ID: 34236307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired nephrogenic diabetes insipidus.
    Khanna A
    Semin Nephrol; 2006 May; 26(3):244-8. PubMed ID: 16713497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of metformin on lithium-induced nephrogenic diabetes insipidus: An experimental study in rats.
    Tas HI; Sancak EB
    Adv Clin Exp Med; 2021 Nov; 30(11):1185-1193. PubMed ID: 34595852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
    Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
    de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME.
    Pedrosa W; Drummond JB; Soares BS; Ribeiro-Oliveira A
    Endocr Pract; 2018 Nov; 24(11):963-972. PubMed ID: 30106630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Haghani M
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1191-201. PubMed ID: 21164566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine concentration impairment in sickle cell anemia: genuine nephrogenic diabetes insipidus or osmotic diuresis?
    de Berny Q; Saint-Jacques C; Santin A; Mattioni S; Steichen O; Chieze R; Frochot V; Letavernier E; Lionnet F; Haymann JP
    Am J Physiol Renal Physiol; 2024 Feb; 326(2):F278-F284. PubMed ID: 38059298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Karimi Z
    Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
    Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
    BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GENETICS IN ENDOCRINOLOGY Pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus.
    Bichet DG
    Eur J Endocrinol; 2020 Aug; 183(2):R29-R40. PubMed ID: 32580146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency.
    Hochberg Z; Even L; Danon A
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):39-44. PubMed ID: 9797845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
    Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus.
    Klein JD; Khanna I; Pillarisetti R; Hagan RA; LaRocque LM; Rodriguez EL; Sands JM
    JCI Insight; 2021 Apr; 6(8):. PubMed ID: 33724959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil reduces polyuria in rats with lithium-induced NDI.
    Sanches TR; Volpini RA; Massola Shimizu MH; Bragança AC; Oshiro-Monreal F; Seguro AC; Andrade L
    Am J Physiol Renal Physiol; 2012 Jan; 302(1):F216-25. PubMed ID: 22031848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
    Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
    Gao C; Higgins PJ; Zhang W
    Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.